Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
– Sell
-262,371
Closed -$29.8M – 64
2024
Q1
$29.8M Sell
262,371
-3,129
-1% -$359K 1.09% 33
2023
Q4
$29.2M Buy
+265,500
New +$26.5M 1.05% 29
2018
Q3
– Sell
-449,300
Closed -$27.4M – 84
2018
Q2
$27.4M Sell
449,300
-646,800
-59% -$39.2M 0.93% 38
2018
Q1
$65.7M Buy
1,096,100
+199,200
+22% +$12M 2.54% 11
2017
Q4
$51.2M Buy
+896,900
New +$49.7M 2.23% 14
2013
Q3
– Sell
-7,200
Closed -$251K – 51
2013
Q2
$251K Buy
+7,200
New +$264K 0.04% 44

Other funds holding ABT

Redmile Group's ABT Position: Q2 2024 in Review

Redmile Group sold out of Abbott (ABT) in Q2 2024, closing a stake of 262,371 shares — an estimated $29.8M sold.

Redmile Group first reported a position in ABT in Q2 2013 and held it in 6 quarters. The position peaked at $65.7M in Q1 2018. 2,872 funds tracked by Wall St. Rank hold ABT as of Q2 2024.

  • Redmile Group reported no remaining Abbott position as of Q2 2024 after selling out during the quarter.
  • Redmile Group sold 262,371 Abbott shares in Q2 2024, an estimated $29.8M.
  • Redmile Group first reported a position in Abbott in Q2 2013 and held it in 6 quarters.
  • Redmile Group's Abbott position peaked at $65.7M in Q1 2018.
  • 2,872 funds tracked by Wall St. Rank held Abbott as of Q2 2024.

Based on Redmile Group's 13F filing for Q2 2024, filed 14 Aug 2024.